Author

Tom Clemmet

Observed name: T Clemmet

OpenAlex ID: A5115629396

Ee377 the Budget Impact of Introducing Zongertinib Into the Formulary for Treatment-naïve and Pretreated Her2-mutant Advanced Nsclc in the United States

2026 · Hasan Basarir, Tom Clemmet, et al. · Value in Health

EPH234 The Estimation of the Prevalent Presymptomatic Type 1 Diabetes Population in Germany Using a Patient Funnel Model

2025 · Aymeric Mahieu, Omar Alsaleh Abdul Jabbar, et al. · Value in Health

EE503 Key Features of Economic Models Used in Submissions to NICE in Dermatology Indications

2024 · T Clemmet, K Campbell, et al. · Value in Health

Works count: 3

Citation count:

H-index:

I10-index: